These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 23084090

  • 1. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH.
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D.
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [Abstract] [Full Text] [Related]

  • 4. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W, Schur S, Köstler WJ, Funovics P, Windhager R, Amann G, Panotopoulos J, Pokrajac B, Brodowicz T.
    Oncology; 2014 Jun; 86(2):122-6. PubMed ID: 24480823
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C.
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [Abstract] [Full Text] [Related]

  • 7. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S.
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y, Elahi A, Denley RC, Rao PH, Brennan MF, Jhanwar SC.
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.
    Clin Cancer Res; 2013 Jan 15; 19(2):450-61. PubMed ID: 23209032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K, Dumas V, Martin-Garcia N, Falzone MC, Voisin MC, Wechsler J, Revuz J, Créange A, Levy E, Lantieri L, Zeller J, Wolkenstein P.
    Arch Dermatol; 2001 Jul 15; 137(7):908-13. PubMed ID: 11453810
    [Abstract] [Full Text] [Related]

  • 12. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
    Friedrich RE, Hartmann M, Mautner VF.
    Anticancer Res; 2007 Jul 15; 27(4A):1957-60. PubMed ID: 17649804
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M, Thiesse P, Ranchere D, Mognetti T, Pinson S, Renard C, Decouvelaere AV, Blay JY, Combemale P.
    PLoS One; 2015 Jul 15; 10(10):e0138386. PubMed ID: 26445379
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De Sio L, Koscielniak E, Sotti G, Treuner J.
    J Clin Oncol; 2005 Nov 20; 23(33):8422-30. PubMed ID: 16293873
    [Abstract] [Full Text] [Related]

  • 16. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution.
    Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, Lozza L, Collini P, Olmi P, Casali PG, Pilotti S, Gronchi A.
    Cancer; 2006 Sep 01; 107(5):1065-74. PubMed ID: 16881077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-grade malignant triton tumor in the lumbar spine: a rare variant of malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation.
    Prieto R, Pascual JM, García-Cabezas MA, López-Barea F, Barrios L, González-Llanos F.
    Neuropathology; 2012 Apr 01; 32(2):180-9. PubMed ID: 21732991
    [Abstract] [Full Text] [Related]

  • 19. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
    Friedrich RE, Kluwe L, Fünsterer C, Mautner VF.
    Anticancer Res; 2005 Apr 01; 25(3A):1699-702. PubMed ID: 16033085
    [Abstract] [Full Text] [Related]

  • 20. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
    Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM.
    Am J Clin Oncol; 2011 Aug 01; 34(4):417-21. PubMed ID: 20838322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.